![](/img/cover-not-exists.png)
Cost-effectiveness analysis of ixekizumab versus secukinumab in patients with psoriatic arthritis and concomitant moderate-to-severe psoriasis in Spain
Schweikert, Bernd, Malmberg, Chiara, Núñez, Mercedes, Dilla, Tatiana, Sapin, Christophe, Hartz, SusanneVolume:
10
Journal:
BMJ Open
DOI:
10.1136/bmjopen-2019-032552
Date:
August, 2020
File:
PDF, 1.24 MB
2020